$AMCO- .09 eps for the quarter and right back to the .14 range.
Until they stop the toxic financing shenanigans, this will be a game. They've run the gamut, from Hanover-Asher-Magna-KBM Worldwide.
I'm not sure why they're choosing to play the game with $70 million available in bank lines.
The AR was a red flag but I saw this in the 10q:
Management intent not aligning with the retail shareholder at this time. I'm curious to see if they do anything about it...aside from entering into more toxic deals now that they're "profitable".
These special situations can sometimes offer the biggest moves when business rebounds IF company distances from financiers. Guess it just depends on they're plan from here.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.